Understanding HIV/AIDS: How the Virus Attacks the Immune System
HIV (Human Immunodeficiency Virus) is a lentivirus that targets CD4+ T helper cells, progressively dismantling cell-mediated immunity. Without treatment, it advances through three stages to AIDS (Acquired Immunodeficiency Syndrome).
Natural History Stages
1. Acute HIV Infection (Seroconversion Syndrome)
- Timing: 2–6 weeks post-exposure.
- Symptoms (40–90%): Fever, maculopapular rash, pharyngitis, lymphadenopathy, myalgia, headache, meningitis, ulcerative esophagitis.
- Virology: Massive viremia (millions copies/mL); high transmission risk.
- Diagnosis: HIV RNA PCR or p24 antigen positive; antibody negative/indeterminate.
2. Chronic HIV (Clinical Latency)
- Duration: Years to decades (median ~10 years untreated).
- Clinical: Asymptomatic or persistent generalized lymphadenopathy (PGL).
- Immunology: Gradual CD4+ decline (~50–80 cells/µL/year); ongoing viral replication in lymphoid tissue.
- Transmission: Possible at all stages; risk correlates with viral load.
3. AIDS (Advanced HIV Disease)
- Definition: CD4+ <200 cells/µL OR AIDS-defining illness (regardless of CD4).
- Opportunistic Infections (OIs):
- PCP (Pneumocystis pneumonia)
- TB (pulmonary/extrapulmonary)
- Cryptococcal meningitis
- Toxoplasma encephalitis
- Cytomegalovirus (retinitis, colitis)
- MAC (Mycobacterium avium complex)
- Esophageal candidiasis, chronic herpes simplex
- Malignancies: Kaposi sarcoma (HHV-8), NHL (EBV-driven), cervical/anal cancer (HPV), hepatocellular carcinoma (HBV/HCV coinfection).
- Neurocognitive: HAND (HIV-associated neurocognitive disorder): asymptomatic → mild → HIV dementia.
- Wasting Syndrome: >10% weight loss + diarrhea/fever/weakness >30 days.
Systemic Effects of HIV
| System | Key Manifestations |
|---|---|
| Immune | CD4+ depletion, inverted CD4:CD8, B-cell hyperactivation, impaired vaccine response |
| Cardiovascular | Accelerated atherosclerosis, myocarditis, cardiomyopathy |
| Renal | HIVAN (focal segmental glomerulosclerosis), tenofovir nephrotoxicity |
| Hepatic | Coinfection HBV/HCV progression, drug-induced liver injury |
| Bone | Osteoporosis, osteonecrosis (AVN) |
| Metabolic | Insulin resistance, lipodystrophy (older ART), dyslipidemia |
Antiretroviral Therapy (ART) — Game Changer
- Goal: Sustained viral suppression (<50 copies/mL) → immune reconstitution, near-normal life expectancy, zero sexual transmission (U=U).
- Regimens: 2–3 drug combinations (INSTI + 2 NRTIs preferred). Single-tablet regimens available.
- Monitoring: Viral load, CD4, renal/hepatic/lipid panels, resistance testing if failure.
Early diagnosis + immediate ART = best outcomes. CDC recommends universal screening ages 13–64; PrEP for high-risk negatives.
HIV & AIDS - Related Articles
- Understanding False Positive HIV Tests: Causes & What to Do
- Talking to Your Partner About HIV Testing: A Guide to Open Communication
- HIV Transmission: Routes, Myths, and Prevention Essentials
- Opportunistic Infections in HIV: Management & Prevention
- Understanding HIV Symptoms: Early Signs & What to Do
- Understanding HIV Symptoms in Teenagers: Signs & Progression
- Protease Inhibitors (PIs) for HIV Treatment: How They Work
